NCT04774510

Brief Summary

When it comes to acute stroke, everyone deserves the best care. Today, more patients can benefit from endovascular treatment (EVT) in a comprehensive stroke center. With the significant advances in C-arm Cone Beam CT (CBCT) imagings directly in the neuro angio-suite (NAS), the investigators are now able to identify, plan and treat stroke patients in the NAS, without the need for a separate CT scan. This provides valuable, time-saving support for critical patients in acute need of EVT. The main objective is to assess the diagnostic confidence of this optimized C-arm Cone Beam CT, named in french ASO, in the NAS for the detection of brain abnormalities and hemorrhagic complications for critical patients with acute stroke. The secondary objectives are to study the variability of the diagnostic accuracy concerning the staging of the stroke, the analysis of the brain vessel, the relevance of artefact reduction post treatment and the amount of dose for this ASO.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 1, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

January 15, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2022

Completed
Last Updated

January 24, 2024

Status Verified

January 1, 2024

Enrollment Period

11 months

First QC Date

February 15, 2021

Last Update Submit

January 23, 2024

Conditions

Keywords

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Outcome Measures

Primary Outcomes (1)

  • diagnostic confidence

    To assess the diagnostic confidence of ASO diagnostic with a centralized radiological reading

    baseline

Secondary Outcomes (2)

  • Assess the degree of inter-observer agreement

    baseline

  • Evaluate diagnostic agreement with conventional diagnostic imaging: MRI and CT scan

    through study completion, an average of 48 hours

Study Arms (1)

Optimized C-ARM CBCT

OTHER

An optimized C-arm CBCT evaluation with a different acquisition geometry and a novel software for the rapid, quality improved and less-artefacts assessment of brain parenchyma and angiogram.

Other: Diagnostic Test: optimized C-Arm Cone Beam Computed Tomography

Interventions

Optimized C-ARM CBCT using new geometry and a novel software can rapidly and accurately detected brain abnormalities and hemorrhagic complications for critical patients with acute stroke. This rapid assessment would eliminate the need for the patient to be imaged in another scanner and be subsequently transported again to another room; all anatomic and physiologic imaging would occur in the neuro angiography suite (NAS).

Also known as: C-ARM CBCT, XperCT Butterfly
Optimized C-ARM CBCT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Being under tutelage or legal guardianship ; Ongoing pregnancy, breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

service de Neuroradiologie interventionnelle NEURI - Hôpital Bicêtre

Le Kremlin-Bicêtre, Kremlin-Bicêtre, 94270, France

Location

MeSH Terms

Conditions

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

  • Vanessa CHALUMEAU, MD

    APHP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2021

First Posted

March 1, 2021

Study Start

January 15, 2022

Primary Completion

November 28, 2022

Study Completion

November 28, 2022

Last Updated

January 24, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations